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Background: Totally laparoscopic (without hand-assist) resection for rectal cancer continues to evolve, and both
obesity and locally advanced disease are perceived to add to the complexity of these procedures. There is a paucity
of data on the impact of obesity on perioperative and oncologic outcomes for totally-laparoscopic rectal cancer
resection (TLRR) for locally advanced disease.
Methods: In order to identify potential limitations of TLRR, a single-institution database was queried and identified 26
patients that underwent TLRR for locally advanced rectal cancers (T3/T4) over a three-year period. Patients were
classified as normal-weight (NW, body mass index (BMI) = 18.5 to 24.9 kg/m2), overweight (OW, BMI = 25 to 29.9 kg/m2)
and obese (OB, BMI >/= 30 kg/m2). Perioperative outcomes, lymph node harvest and margin status were assessed.
Results: Seven patients were classified as NW (26.9%), 12 as OW (46.2%) and 7 as OB (26.9%). Age, tumor stage, gender
and American Society of Anesthesiologists (ASA) scores were similar. OB had more co-morbidities (median 3.0, range
0.0 to 5.0 vs. 2.0, range 0.0 to 3.0 for NW and 1.0, range 0.0 to 3.0 for OW). Five patients had tumors <5 cm from anal
verge (NW=2; OW=1; OB= 2). A median of 19.0, range 9.0 to 32.0; 20.0, range 9.0 to 46.0 and 19.0, range 15.0 to 31.0
lymph nodes were retrieved in the NW, OW and OB, respectively (Not Significant (NS)). Median node ratios for NW, OW
and OB were 0.32, 0.13 and 0.00, respectively. All groups had negative proximal and distal margins. Radial margins were
negative for 100% of NW, 83.3% of OW and 85.7% of OB (NS). Conversion rates were 14.3% for NW, 16.7% for OW & 0%
for OB (NS). NW, OW and OB had complication rates of 28.3%, 33.3% and 14.3%, respectively. Median operative time,
median estimated blood loss and median length of hospital stay were similar for all groups.
Conclusion: The perceived limitation that obesity would have on TLRR was not demonstrated by the analyzed data.
Although our findings are limited by the modest sized cohort, the results suggest that it is reasonable to offer TLRR to
obese patients with rectal cancer.
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The introduction of laparoscopic rectal cancer surgery
raised concerns about the feasibility, safety and oncolo-
gic adequacy of this modality. In recent years, the lap-
aroscopic approach has come to be accepted as
technically feasible and safe [1-4], with the TLRR gaining
increasing acceptance.
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reproduction in any medium, provided the orrespectively, reported as obese [1]. It is clear that the chal-
lenging situation of applying TLRR to obese patients is
being encountered more frequently. In the recent past, the
presence of locally advanced disease was considered a
contraindication to TLRR. However, the modality is being
increasingly used as locally advanced disease in obese
patients is encountered more frequently [1].
Obese patients undergoing laparoscopic colorectal sur-
gery present a technical challenge. Blood loss, duration
of surgery and conversion rates have been reported to be
greater for obese patients compared to the non-obese (1,
3 and 4). However, morbidity and mortality are compar-
able for both groups [1,3,4]. Adequacy of oncologic
resections has also been verified in laparoscopic colonLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Demographics and other characteristics
Characteristic Normal weight Overweight Obese N=7
N=7 N=12
Sex
Male; no (%) 5 (71.4%) 8 (66.7%) 2 (28.6%)
Female; no (%) 2 (28.6%) 4 (33.3%) 5 (71.4%)
Median age (yr) 65 63 66
Range (yr) 52 to 85 46 to 86 52 to 76
Median BMI(kg/m2) 20.9 28.2 36.1
Range (kg/m2) 18.8 to 24.9 25.5 to 29.8 31.1 to 41.5
Median no. of comorbidities 2.0 1.0 3.0
Range 0.0 to 3.0 0.0 to 3.0 0.0 to 5.0
Median ASA score 2.0 2.0 3.0
Range 2.0 to 4.0 2.0 to 3.0 2.0 to 4.0
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nant colonic conditions are included in most studies and
few reports focus exclusively on laparoscopic colectomy
for cancer [1,3-6]. In some cases colon and rectal can-
cers have been combined, and very few studies have
evaluated the impact of obesity on TLRR [1,7]. Rather
than compare outcomes of purely laparoscopic tech-
nique for rectal cancer resection between obese and
non-obese patients, some series have mixed up cases of
hand-assisted laparoscopic and purely laparoscopic tech-
niques, in drawing comparison between the two groups.
As such, there is insufficient broadly applicable data to
guide the selection of obese patients for TLRR in the
management of locally advanced rectal adenocarcinoma.
The goal of this study was to analyze the impact of
obesity on perioperative outcomes for TLRR surgery
done for locally advanced rectal cancer. We also assessed
the lymph node retrieval and margin status of these
operations as surrogates for oncologic adequacy.
Methods
Between July 2007 and March 2010, 26 patients with lo-
cally advanced rectal cancer (T3 or T4) underwent re-
section using TLRR. Preoperative staging included
endorectal ultrasonography, thoracoabdominopelvic
computerized tomographic scan or pelvic magnetic res-
onance imaging. After obtaining Institutional Review
Board approval, a prospectively maintained database was
queried for demographic, oncologic, perioperative, mor-
bidity, mortality and pathologic data. Data collected
included age, gender, body mass index (BMI), preopera-
tive diagnosis, neoadjuvant therapy, distance to anal
verge, co-morbidities, type of operation, ASA score, op-
erative time, estimated blood loss, type of operation,
intraoperative and postoperative complications, length
of hospital stay, conversion rates, number of lymph
nodes retrieved and margin status. Patients were cate-
gorized as normal weight (BMI 18.5 to 24.9 kg/m2),
overweight (BMI 25 to 29.9 kg/m2) and obese (BMI >/=
30 kg/m2). NW, OW and OB were compared to identify
potential differences in operating time, estimated blood
loss, length of stay, complication, conversion, lymph
node retrieval and margin status.
Technique
Four ports were routinely used, with placement in the
left upper, right upper, right lower and suprapubic posi-
tions. Occasionally a fifth port in the left lower quadrant
was inserted to facilitate retraction of the colon when a
bulky mesentery was encountered, particularly in obese
patients. Lesions were confirmed by rectal or procto-
scopic examination, as well as preoperative tattooing.
The medial to lateral approach was utilized for our dis-
section and mobilization. The inferior mesenteric artery(IMA) was dissected and staple divided. The left ureter
was identified, and the prescaral plane was carefully
developed with preservation of the autonomic nerve
fibers using the technique of sharp total mesorectal exci-
sion. The rectum was divided at least 3 cm distal to the
tattoo using an articulating stapling device via the supra-
pubic port. The splenic flexure was mobilized as deemed
necessary. A small 4 to 5 cm incision was then made for
specimen extraction and proximal transection, and a cir-
cular stapler was used for all anastomoses.
Results
Demographics
Twenty-six total patients; 15 male (57.7%) and 11 female
(42.3%) with T3 or T4 rectal cancers are reported in this
series (Table 1). They were categorized into NW (n= 7
(26.9%)), OW (n= 12 (46.2%)) and OB (n = 7 (26.9%)).
The median ages (NW=65 yr, OW=63 yr, and
OB= 66 yr) were also similar (Table 1). The median
BMIs for the three groups were 20.9 kg/m2 (NW),
28.2 kg/m2 (OW) and 36.1 kg/m2 (OB).
Altogether, there were 22 (84.6%) T3 tumors and 4
(15.4%) T4 tumors. There was a comparable distribution
of tumor stages across the three BMI groups (Table 2).
A total of 77% of patients (n = 20) had rectal cancer
while 23% (n = 6) had rectosigmoid cancers. The recto-
sigmoid cancers were preoperatively and intraoperatively
identified and treated as cancers in the upper third of
the rectum. In the NW group, 57.1% underwent neoad-
juvant therapy; as opposed to 16.7% of OW patients and
none of the OB patients. The presence of co-morbidities
, including coronary artery disease, hypertension, dia-
betes mellitus, hyperlipidemia, chronic kidney disease,
acute kidney disease, asthma, chronic obstructive pul-
monary disease, hypothyroidism and hyperthyroidism,
was documented for each patient. In terms of medical
co-morbidities, NW patients had a median of 2.0 co-
Table 2 Tumor characteristics and distribution
Characteristic Normal weight Overweight Obese
T stage
T3 6 9 7
T4 1 3 0
Neoadjuvant treatment 4 2 0
Very Low Tumor (<5 cm
from anal verge)
2 1 2
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groups. The median ASA scores were 2.0, 2.0, and 3.0
respectively.
Very low rectal tumors were defined as those that are
less than 5 cm from the anal verge. Distance from the
lower edge of the tumor to the anal verge was recorded
for the patients. A total of five patients had very low
tumors (NW=2; OW=1; OB= 2).Perioperative outcomes
The median operative times for the NW, OW and OB
groups were 195.0 minutes; 240.5 minutes and 264.0
minutes, respectively. There were no significant differ-
ences among the groups with respect to length of stay or
blood loss (Table 3). The rates of conversion to open
procedure were comparable for the NW and OW groups
at 14.3% and 16.7%, respectively, while the OB groupTable 3 Outcomes
Parameter Normal weight Overweight Obese
N=7 N=12 N=7
Median LOS (days) 12.0 7.0 5.0








Range 125.0 to 351.0 127.0 to 578.0 143.0 to 359.0
Median number of lymph
nodes retrieved
19.0 20.0 19.0
Range 9.0 to 32.0 9.0 to 46.0 15.0 to 31.0
Median lymph node ratio
(positive/total)
0.32 0.13 0.00
Range 0.00 to 0.72 0.00 to 0.61 0.00 to 0.83
Negative margins (radial) 7 (100%) 10 (83.3%) 6(85.7%)
Negative margins
(proximal/distal)
7 ([100%) 12 (100%) 7 (100%)
Conversion 1 (14.3%) 2 (16.7%) 0 (0%)
No. of patients
with complications
2 (28.3%) 4 (33.3%) 1 (14.3%)
Mortality - 1 -had no conversions. Major and minor complications oc-
curred in 28.3% of NW, 33.3% of OW and 14.3% of OB
(Tables 3 and 4). For the purpose of standardization, the
complications were also graded using the Clavien Score.
The only mortality in the series was recorded in the OW
group as a result of postoperative massive pulmonary
embolism in a patient who underwent laparoscopic
abdominoperineal resection for T3 rectal cancer. This
patient had neoadjuvant chemoradiation therapy.Oncologic parameters
The three groups were compared for lymph node re-
trieval on pathologic examination of resected specimens,
as well as proximal, distal and radial margins. The me-
dian lymph node harvest was 19.0 for the NW group,
20.0 for the OW group, and 19.0 for the OB group. Me-
dian node ratios for NW, OW and OB were 0.32, 0.13
and 0.00, respectively. All patients in the study had nega-
tive proximal and distal bowel margins. Radial margin
negativity rates were 100%, 83.3% and 85.7% for NW,
OW and OB, respectively.Discussion
There is a paucity of data on the relationship between
obesity and outcomes of totally laparoscopic resections
for rectal cancer (TLRR). Bege et al. were the first to
compare outcomes of laparoscopic rectal resection for
cancer between obese and non-obese patients. They
reported increased conversion rate and operative time
for obese patients but the overall morbidity was compar-
able for both groups [1]. The bulk of data on the impact
of obesity on colorectal surgery is predominantly from
colonic resections. Results have been conflicting, with
Delaney et al. reporting no difference in operative time,
complication rate or cost [2] while other groups
reported significant differences in those parameters [3,4].Table 4 Complications
Complication Clavien
Score
Normal weight Overweight Obese
(n = 7) (n = 12) (n = 7)
Sacral decubitus ulcer Grade I 1 - -
Acute renal failure Grade I 1 - -
Surgical site infection Grade I 1 - 2
Ileus Grade I 1 - 1
Pulmonary embolism Grade II 1 1 -
Pneumonia Grade II 2 - -
UTI Grade II 1 1 -
Pelvic abscess Grade IIIa 2 - -
Anastomotic leak Grade IIIb 1 - -
Bleeding requiring
reoperation
Grade IIIb 1 - -
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nically more demanding. This may at least partly explain
the limited availability of this procedure and lack of rele-
vant data. Concerns about nerve preservation, complete
total mesorectal excision, and adequate lymph node har-
vest are still unanswered in this setting.
In view of the peculiar technical challenges of laparo-
scopic rectal cancer surgery, it would be inappropriate
to simply extrapolate the data from laparoscopic colonic
resections [1]. The CLASSIC trials by Guillou et al. in
2005 and 2007 are Level 1 studies that addressed short-
term and long-term outcomes of laparoscopic assisted
colorectal cancer surgery [5,6].
TLRR is evolving. This unique study specifically
addresses a TLRR with emphasis on locally-advanced
disease defined as T3/T4. Additionally, the role of vary-
ing levels of obesity is examined. Besides the association
between obesity and occurrence of colorectal cancer [8],
the safety, feasibility, short-term outcomes and oncologic
effectiveness of this approach could be affected by obes-
ity. This was examined in the present study. Median age,
gender distribution, cancer location, tumor stage, med-
ical comorbidities, ASA score, lymph node harvest and
margin positivity rates were comparable for the three
BMI groups studied.
The presence of lymph node metastasis is important
for predicting the clinical outcome of patients who have
undergone radical surgery for colorectal carcinoma and
for making decision on need for adjuvant therapy.
Therefore, an accurate measurement of the pathologic
status of the tumor lymph nodes in the specimen is im-
portant for reducing the risk of understaging [9]. This
study showed no difference in the median number of
lymph nodes harvested in each of the three weight
groups (NW=19.0, range 9.0 to 32.0; OW=20.0, range
9.0 to 46.0; OB= 19.0, range 15.0 to 31.0). Median node
ratios for NW, OW and OB (0.32, range 0.00 to 0.72;
0.13, range 0.00 to 0.61 and 0.00, range 0.00 to 0.83 re-
spectively) also did not show any significant difference.
Although the AJCC and IUAC guidelines [10] suggest
>12 lymph nodes as an adequate harvest for colon can-
cer, it is unclear whether these node thresholds should
apply to rectal cancer especially for patients who had
neoadjuvant treatment. Nonetheless, in the present
study of the laparoscopic technique, the average nodal
harvest was well in excess of these recommendations.
However, Gorog et al. reported a finding of significantly
lower number of retrieved lymph nodes from rectal re-
section specimens in patients with BMI >/= 25 kg/m2
compared to those with BMI< 25 kg/m2 when the
length of the resected specimen was less than 16 cm
[11]. These findings indicate that the quantity and ad-
equacy of mesorectal lymph node dissection for rectal
cancer has not been firmly established.Negative proximal/distal margin rates were 100% for
the NW, OW and OB groups. Negative radial margin
rates were 100%, 83.3% and 85.7% for the NW, OW and
OB groups respectively. The two patients in the OW
group with positive radial margin presented with
obstructing tumors which required prompt surgical
intervention that made it impossible for them to
undergo neoadjuvant chemoradiation. Both were extra-
luminal, invasive rectal tumors with adherence to sur-
rounding structures. The only patient in the OB group
with positive radial margin presented with bleeding rec-
tal tumor necessitating prompt surgery, which also pre-
vented administration of neoadjuvant chemoradiation.
Operative time increased slightly with progression
from non-obese to obese patients, but was not signifi-
cant. The small numbers in this study certainly do not
contradict the findings from other studies that have
documented longer duration of surgery for obese
patients [1]. Median blood loss was similar for the three
groups, standing at 200 ml.
The rate of complications for the OB group (14.3%) is
almost half of that for NW (28.6%) and OW (33.3%)-an
unusual observation. This may be explained by the fact
that none of the patients in the OB group underwent
neoadjuvant chemoradiotherapy compared to 57.1% of
NW and 16.7% of OW. This observation is congruent
with earlier studies which have associated neodjuvant
chemoradiation with greater technical difficulty and
increased perineal wound complications in laparoscopic
rectal cancer resection [12]. For ease of universal refer-
ence and standardization of documentation, each com-
plication was graded using the Clavien Score.
The overall conversion rate in this series of locally-
advanced rectal cancers (T3/T4) is 11.5%. Conversion
rate for laparoscopic rectal cancer resection is documen-
ted in the Conventional versus Laparoscopic-Assisted
Surgery in Colorectal Cancer [CLASICC] trial to be
34%. More recently it has been documented in the lit-
erature as ranging from 2.8 to 9.8% [13-16], for all T-
stages combined. The authors’ experience with lower
conversion rates in locally advanced tumors likely
reflects the continual refinement that laparoscopic rectal
surgery has undergone since the CLASICC trial, in
addition to careful patient selection.
In this study, the NW group had a longer median
length of hospital stay than the OW and OB groups.
The presence of an outlier in the NW group with length
of stay of 30 days is noted. The postoperative course in
this patient was complicated by prolonged ileus initially,
followed by rapid atrial fibrillation, fungemia, pneumo-
nia and superficial wound infection.
Over the years concerns have arisen regarding the
results of laparoscopic rectal cancer resection compared
with open conventional resection. Many studies have
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tal cancer resection compared to the open approach.
However, this shortcoming is often offset by shorter hos-
pital stays, earlier return of bowel function, decreased
blood loss and better preservation of autonomic nerves
[17,18]. In terms of five-year local and distant recurrence
rates, five-year overall survival and disease-free survival,
results are comparable, without the benefit of large
series [14-16,19,20].
Conclusion
The present series adds to the body of literature support-
ing the feasibility and safety of the totally laparoscopic
technique in treating obese patients with locally advanced
(T3/T4) rectal cancers which could also be confirmed with
further studies. Both perioperative outcomes and surro-
gates of oncologic surgical quality from TLRR are compar-
able to the reported results for non-obese patients in the
current literature. While this study is limited by a modest
cohort, the data support that totally laparoscopic rectal re-
section may be an appropriate and safe technique applic-
able to obese patients.
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